Publications by authors named "Daniela Annenelie Bota"
Article Synopsis
- Recurrent glioblastoma multiforme (GBM) has a poor prognosis, but the NovoTTF-100A™ System has shown improved overall survival compared to previous trials, offering a median of 9.6 months versus 6.6 months in traditional therapies.
- Data from a post-marketing registry (PRiDe) involving 457 patients indicated that higher daily compliance and better performance status positively influenced survival rates, with higher one- and two-year survival rates compared to earlier trial results.
- Adverse events were primarily mild to moderate skin reactions, similar to those reported in prior studies, with no new safety concerns identified.
Radiation-induced midbrain fibrosarcoma is a rare, highly aggressive tumor, which is associated with poor prognosis. We present the case of a 48-year old man with brainstem fibrosarcoma 20 years following radiation therapy received for a pituitary tumor. We discuss this case in the context of the diagnostic criteria for these tumors, and previous reports of secondary and primary sarcomas of the central nervous system.
View Article and Find Full Text PDF